Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse 26th Annual Healthcare Conference

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Credit Suisse 26th Annual Healthcare Conference on Tuesday, Nov. 7, 2017 at 9:45 a.m. MT (11:45 a.m. ET/4:45 p.m. GMT) from The Phoenician in Scottsdale, AZ. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171031006115/en/